GRI Bio, Inc. GRI
2.05
(0.04)
(1.91%)
as of 25 Sep
- Market cap
- $4.6M
- P/E
- 0.0×
Follow GRI
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | — | — | — | — | — |
P/S ratio |
— | — | — | 0.00 | — | — | — | — | — |
P/FCF ratio |
— | — | — | 0.00 | — | — | — | — | — |
P/Operating CF |
— | — | — | (54,496,333.59) | — | — | — | — | — |
P/B ratio |
— | — | — | 0.00 | — | — | — | — | — |
Price to Tangible BV |
— | — | — | 0.00 | — | — | — | — | — |
EV/Sales |
— | — | — | 0.00 | — | — | — | — | — |
EV/EBITDA |
— | — | — | 0.00 | — | — | — | — | — |
EV/Operating CF |
— | — | — | (11,881,553.55) | — | — | — | — | — |
EV/FCF |
— | — | — | (11,875,144.94) | — | — | — | — | — |
Quick Ratio |
— | 1.26 | 4.73 | 0.05 | 3.07 | 0.00 | 0.67 | 3.07 | 3.11 |
Current Ratio |
— | 1.31 | 4.85 | 0.30 | 3.32 | 0.16 | 1.09 | 3.43 | 3.25 |
Net Debt/EBITDA |
— | 0.14 | 1.21 | 0.02 | 0.81 | 0.00 | 0.19 | 0.61 | 0.69 |
Debt/Assets |
0.00% | 0.00% | 5.94% | 1.47% | 0.86% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.08 | (0.01) | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
— | 0.55 | 0.83 | 0.77 | 0.89 | 0.34 | 0.69 | 0.85 | 0.85 |
Capex/Depreciation |
— | 0.00 | 0.00 | (0.03) | 0.00 | (0.01) | 0.00 | 0.00 | (0.75) |
Interest Coverage |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| — | (256.19%) | (205.77%) | (547.95%) | (426.35%) | (153.45%) | 1,908.78% | (471.59%) | (238.17%) | |
| — | (1,349.37%) | (140.95%) | (184.36%) | (200.28%) | (73.80%) | (780.89%) | (232.73%) | (166.00%) | |
ROIC |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | (2,820.54%) | (111.20%) | 311.30% | (157.95%) | 191.72% | (5,321.22%) | (254.03%) | (200.87%) |
Average Days of Receivables |
— | — | — | 0.00 | — | — | — | — | — |
Research and Development Expense of Revenue |
— | 0.00% | 0.00% | 3,707.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 1,181.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | 0.00% | 154.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
— | — | — | 0.00 | — | — | — | — | — |
Graham Number |
— | — | — | 2.79 | — | — | — | — | — |
Earnings Yield |
— | — | — | 0.00% | — | — | — | — | — |
Free Cash Flow Yield |
— | — | — | 0.00% | — | — | — | — | — |
Revenue per Share |
— | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
— | (10.44) | (0.81) | (0.82) | (1.27) | 0.00 | (89,900.00) | (1,324.77) | (103.73) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (80.00) | 0.00 | (0.03) |
Free Cash Flow per Share |
— | (10.44) | (0.81) | (0.82) | (1.27) | 0.00 | (89,980.00) | (1,324.77) | (103.76) |
Cash per Share |
— | 2.70 | 1.08 | 0.02 | 1.15 | 0.00 | 18,080.00 | 773.54 | 83.80 |
Shareholders Equity per Share |
— | 0.67 | 0.91 | (0.32) | 0.89 | 0.00 | 2,590.00 | 620.31 | 61.18 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.67 | 0.91 | (0.32) | 0.89 | 0.00 | 2,590.00 | 620.31 | 61.18 |
Free Cash Flow |
— | (2.37) | (2.88) | (3.71) | (8.31) | (1.09) | (9.00) | (8.61) | (10.19) |
Working Capital |
— | 0.15 | 3.11 | (1.55) | 5.68 | (1.68) | 0.24 | 3.98 | 5.95 |
Capital Expenditures |
— | 0.00 | — | 0.00 | — | 0.00 | (0.01) | — | 0.00 |
Net Current Asset Value |
— | 0.15 | 2.86 | (1.73) | 5.61 | (1.70) | 0.24 | 3.91 | 5.93 |
EV/EBIT |
— | — | — | 0.00 | — | — | — | — | — |
Capex to Sales |
— | — | — | 0.02 | — | 0.00 | 0.00 | — | 0.00 |
Net Profit Margin |
— | 0.00% | 0.00% | (4,822.00%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Price to Operating Income |
— | — | — | 0.00 | — | — | — | — | — |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 0.38 | 206.00 | 37.00 | 0.51 | 55.00 | 263.50 | 1.00 | 1.33 |
Cash ROIC |
— | (309.90%) | (39.58%) | 278.59% | (63.57%) | 67.39% | (435.32%) | (95.09%) | (71.57%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | — | — | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
— | 174,348.33 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | 0.00 | 0.00 | — | 0.00 | 0.00 | — | — | — |
Average Payables |
— | 0.27 | 0.27 | 0.74 | 1.07 | 1.11 | 1.35 | 1.15 | 1.37 |
Average Assets |
— | 0.32 | 2.46 | 2.62 | 4.65 | 4.36 | 1.67 | 4.35 | 7.20 |
Average Common Equity |
— | 1.68 | 1.68 | 0.88 | 2.18 | 2.10 | (0.68) | 2.15 | 5.02 |
Columns are period end dates